OTC skin protectants
This article was originally published in The Rose Sheet
Executive Summary
FDA denies Cosmetic, Toiletry and Fragrance Association request to stay enforcement action on OTC skin protectant final monograph in a Feb. 24 letter to the association. Request to stay action is "moot" after FDA granted CTFA's citizen petition request to include the indications "help prevent" and "chafing" in monograph in a technical amendment published Dec. 9 in the Federal Register (1"The Rose Sheet" Dec. 15, 2003, p. 10). Compliance dates for OTC skin protectant drug products are June 6, 2005 for products with annual sales less than $25,000 and June 4, 2004 for all others. FDA released the rule June 4 (2"The Rose Sheet" June 9, 2003, p. 3)...
You may also be interested in...
Skin Protectant Rule Amended To Include Prevention, Chafing Indications
FDA will permit optional labeling language for OTC skin protectant drug products to include the indications "helps prevent" and "chafed" under a technical amendment to the final monograph, published in the Federal Register Dec. 9
Biotherm Biovitamin Marks Brand Foray Into Teen Skin Care Segment
Biotherm will enter the teen skin care market in August with Biovitamin cleanser and moisturizer targeted to young women ages 15-21 with normal to combination skin, the L'Oréal division said
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”